ARMISTICE CAPITAL LLC 13D and 13G filings for Shuttle Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:53 pm Purchase | 2025-03-31 | 13G | Shuttle Pharmaceuticals Holdings, Inc. SHPH | ARMISTICE CAPITAL LLC | 17,785 9.990% | 5,543 (+45.28%) | Filing |
| 2025-02-14 4:55 pm Purchase | 2024-12-31 | 13G | Shuttle Pharmaceuticals Holdings, Inc. SHPH | ARMISTICE CAPITAL LLC | 12,242 7.510% | 12,242 (New Position) | Filing |